These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28364126)

  • 1. Carbon Dots' Antiviral Functions Against Noroviruses.
    Dong X; Moyer MM; Yang F; Sun YP; Yang L
    Sci Rep; 2017 Mar; 7(1):519. PubMed ID: 28364126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.
    Ali ES; Rajapaksha H; Carr JM; Petrovsky N
    Antiviral Res; 2016 Sep; 133():14-22. PubMed ID: 27421712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles.
    Broglie JJ; Alston B; Yang C; Ma L; Adcock AF; Chen W; Yang L
    PLoS One; 2015; 10(10):e0141050. PubMed ID: 26474396
    [TBL] [Abstract][Full Text] [Related]  

  • 8.  The dominant role of surface functionalization in carbon dots' photo-activated antibacterial activity.
    Abu Rabe DI; Al Awak MM; Yang F; Okonjo PA; Dong X; Teisl LR; Wang P; Tang Y; Pan N; Sun YP; Yang L
    Int J Nanomedicine; 2019; 14():2655-2665. PubMed ID: 31118606
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human norovirus inhibition by a human milk oligosaccharide.
    Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
    Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.
    Leuthold MM; Dalton KP; Hansman GS
    J Virol; 2015 Feb; 89(4):2378-87. PubMed ID: 25505081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.
    Huhti L; Blazevic V; Nurminen K; Koho T; Hytönen VP; Vesikari T
    Arch Virol; 2010 Nov; 155(11):1855-8. PubMed ID: 20721592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain.
    Zheng L; Wang W; Liu J; Huo Y; Qin C; Wang M; Shen S
    Arch Virol; 2017 Dec; 162(12):3863-3868. PubMed ID: 28866835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnologically produced fucosylated oligosaccharides inhibit the binding of human noroviruses to their natural receptors.
    Derya SM; Spiegel H; Hanisch FG; Morozov V; Schroten H; Jennewein S; Parschat K
    J Biotechnol; 2020 Jul; 318():31-38. PubMed ID: 32387450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surface-exposed loop region of norovirus GII.3 VP1 plays an essential role in binding histo-blood group antigens.
    Zhang G; Wang J; Liu J; Zheng L; Wang W; Huo Y; Sun X
    Arch Virol; 2019 Jun; 164(6):1629-1638. PubMed ID: 30968211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobody binding to a conserved epitope promotes norovirus particle disassembly.
    Koromyslova AD; Hansman GS
    J Virol; 2015 Mar; 89(5):2718-30. PubMed ID: 25520510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinities of human histo-blood group antigens for norovirus capsid protein complexes.
    Han L; Kitova EN; Tan M; Jiang X; Pluvinage B; Boraston AB; Klassen JS
    Glycobiology; 2015 Feb; 25(2):170-80. PubMed ID: 25395406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus GII.4 antibodies in breast milk and serum samples: their role preventing virus-like particles binding to their receptors.
    Khodayar-Pardo P; Martínez-Costa C; Carmona-Vicente N; Buesa J
    Pediatr Infect Dis J; 2014 Jun; 33(6):554-9. PubMed ID: 24830517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.